Jonathan M. Spergel, MD, PhD
Professor of Pediatrics
Chief, Allergy Section
Stuart E. Starr Chair of Pediatrics
Director of Center for Pediatric Eosinophilic Disease
The Children's Hospital of Philadelphia
Perelman School of Medicine at Univ. of Pennsylvania
Dr. Spergel is a Professor of Pediatrics and holder of Stuart Starr Chair of Pediatrics at the Perelman School of Medicine at University of Pennsylvania and Chief of the Allergy Section at Children’s Hospital of Philadelphia and director of Center for Pediatric Eosinophilic Disorders. He graduated Magna Cum Laude from Princeton University in Chemistry. He received his medical and graduate education at the Mount Sinai School of Medicine and completed his pediatric residency at Yale-New Haven Hospital. His clinical and post-graduate research training in Allergy and Immunology were completed at Children’s Hospital, Harvard Medical School, Boston, MA. Under the mentorship of Dr. Geha, Dr. Spergel identified a murine model of atopic march and atopic dermatitis. This model is currently being used for multiple atopic diseases including all aspects of food allergy. Dr. Spergel is Board Certified in Pediatrics and Allergy and Immunology. He is a fellow in American Academy of Allergy Asthma and Immunology (AAAAI), American College of Allergy, Asthma and Immunology, American Assoc of Pediatrics, Philadelphia College of Physicians and others.
His research interests have focused on all aspects of food allergy and atopic dermatitis. Some of his important works was the identification that peanut allergy can be outgrown, identification of genetic risk factors for Eosinophilic Esophagitis and the role of basophils and T cells in Eosinophilic Esophagitis. He has been a member of the medical advisory board for American Partnership for Eosinophilic Disorders, International Association for Food Protein Induced Enterocolitis, Food Allergy Resedarch and Education and Food Allergy Anaphylaxis Connection Team. He has published over 150 articles in the field and is funded by NIH, PCORI, FARE and EATS foundations as well as partnerships with DBV Technologies, AImmune Therapeutics, and Regeneron. He has spoken national and international in the field of eosinophilic esophagitis, food allergy and atopic dermatitis.